The refractory gout market is growing because of the rising prevalence of gout brought on by aging populations and changes in ...

New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia. When it comes to metabolic diseases, conditions like diabetes and hyperlipidemia ...

The pharmacologic options to treat gout are fairly limited, and each option has benefits and potential adverse effects. These limited options, coupled with the lack of symptoms outside of those ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...

The current target of gout treatment is to reduce levels down to 6 mg/dL or less. SEL-212 is based on a uricase enzyme (pegadricase) that breaks down uric acid in the blood combined with an immune ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

If you have gout, a doctor can help you develop a treatment plan to manage your flares. This may include changes to your diet and medications that can help prevent gout attacks. This is not a ...

Gender disparities in heart care affect outcomes. Women often get less treatment than men. Learn the causes and solutions ...

METHODS Prospective, parallel, open study of 86 consecutive male patients with primary chronic gout. Forty nine patients (26 normal excretors and 23 under excretors) were given allopurinol 300 mg/day ...